Quest Diagnostics 2007 Annual Report Download - page 45

Download and view the complete annual report

Please find page 45 of the 2007 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

Item 9A. Controls and Procedures
Conclusion Regarding Effectiveness of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our Chief Executive Officer
and our Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as
defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended). Based upon
that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure
controls and procedures were effective as of the end of the period covered by this annual report.
Management’s Report on Internal Control Over Financial Reporting
See page 61.
Changes in Internal Control
On May 31, 2007, the Company completed the acquisition of AmeriPath. AmeriPath disclosed two “material
weaknesses” in internal controls over financial reporting in its 2006 Annual Report on Form 10-K and first
quarter 2007 Quarterly Report on Form 10-Q. The material weaknesses relate to the following: (i) the adequacy
of general controls relating to certain AmeriPath information technology systems, and (ii) the adequacy of the
support and analysis for accounts receivable allowances. Subsequent to the acquisition of AmeriPath, the
Company has revised certain of AmeriPath’s controls, and has implemented oversight procedures related to
accounts receivable allowances and general controls in its information technology systems. These changes have
been designed to ensure adherence with the Company’s overall methodology, supervision and monitoring
processes related to internal control over financial reporting. After giving consideration to the control weaknesses
identified at AmeriPath, management believes that the financial statements included in this Annual Report on
Form 10-K present fairly in all material respects the Company’s consolidated financial condition, results of
operations and cash flows for the periods presented.
During the fourth quarter of 2007, there have been no other changes in our internal control over financial
reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) that materially affected, or is
reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information
None.
36